Their findings declared a novel underlying molecular mechanism of the SNHG6/miR-944, LINC00520/miR-577, PCAT6/miR-326, DANCR/miR-577, and KCNMB2-AS1/miR-374a-3p signaling axis in promoting DN progression [151]. This evidence concerns the gene KCNMB2 and liver dysplastic nodule.